What was corrected and how
A subsequent correction by the company to the contents of an already published filing.
| Item | Details |
|---|
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To create new pipelines following those currently under out-licensing activities, which is necessary to achieve sustainable growth in the pharmaceutical business, and to apply the funds to research and development and working capital.